Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial Comparing Efficacy of Sorafenib Versus Sorafenib In Combination With Low Dose Cisplatin /Fluorouracil Hepatic Arterial InfUSion Chemotherapy in Patients With Advanced Hepatocellular Carcinoma

NCT01214343 is registered in ClinicalTrials.gov with Ministry of Health, Labour and Welfare, Japan as lead sponsor.

NCT NCT01214343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01214343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial Comparing Efficacy of Sorafenib Versus Sorafenib In Combination With Low Dose Cisplatin /Fluorouracil Hepatic Arterial InfUSion Chemotherapy in Patients With Advanced Hepatocellular Carcinoma
Lead sponsor
Ministry of Health, Labour and Welfare, Japan
Phase
Phase 3
Overall status
Unknown status
Start date
October 31, 2010
Completion date
September 30, 2013
Enrollment
190 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

advanced hepatocellular carcinoma, carcinoma, carcinoma, hepatocellular, liver neoplasms, neoplasms